Spok (SPOK) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
29 Oct, 2026Executive summary
Q3 revenue fell 2.6% YoY to $33.0M; operating income rose 29.3% to $5.6M, net income reached $9.7M including a $7.5M spectrum-sale gain, and adjusted EBITDA rose 29.6% to $8.6M.
Strategic realignment was completed in Q3 after reducing the workforce by ~10%; annualized savings are expected to exceed $6.0M, with resources redirected to Care Connect Suite and AI initiatives.
Priorities include cash generation, shareholder returns, Care Connect investment and using AI to improve operational efficiency and product development speed.
Financial highlights
Q3 revenue was $33.0M versus $33.9M YoY; 9M revenue was $101.2M versus $105.8M, down 4.4%.
Q3 GAAP net income was $9.7M versus $3.2M; diluted EPS was $0.46 versus $0.15. 9M net income was $15.8M versus $13.0M.
Q3 operating income rose to $5.6M from $4.4M; 9M operating income was $13.5M versus $15.8M.
Q3 adjusted operating expenses were $26.1M, down 8.5% YoY; 9M adjusted operating expenses were $82.6M, down 5.3%.
Q3 adjusted EBITDA was $8.6M versus $6.6M; 9M adjusted EBITDA was $23.0M versus $22.3M.
Outlook and guidance
FY 2026 guidance reiterated: revenue $132.5M–$139.5M, including wireless revenue of $67.0M–$70.0M and software revenue of $65.5M–$69.5M.
FY 2026 adjusted EBITDA guidance remains $28M–$32M, based on expected realignment impacts and visibility into the product sales pipeline.
Annualized savings from the realignment are expected to exceed $6.0M in payroll, related and other operating expenses.
Year-end 2026 cash and cash equivalents expected at $28M–$32M; operating cash flow and cash on hand are expected to cover anticipated cash requirements.
Latest events from Spok
- All board nominees and proposals were approved, with results to be filed with the SEC.SPOK
AGM 2026 - Recurring revenue, strong cash flow, and top hospital relationships fuel growth and returns.SPOK
Investor presentation - Software bookings up 92%, record EBITDA, and strong capital returns in Q2 2026.SPOK
Q2 2026 - Key votes include director elections, auditor ratification, and executive compensation approval.SPOK
Proxy filing - Board recommends all proxy proposals, highlighting strong governance and ESG focus.SPOK
Proxy filing - Recurring revenue and top hospital relationships fuel growth, cash flow, and shareholder returns.SPOK
Investor presentation - Q1 2026 saw revenue fall 8.5%, but software managed services surged 57% and $8M was returned.SPOK
Q1 2026 - Software bookings surged over 64% year-over-year, driving backlog and ARPU growth.SPOK
Q3 2024 - Q2 revenue and net income declined, but software bookings rose and capital returns remained strong.SPOK
Q2 2024